A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
about
Novel agents and treatment techniques to enhance radiotherapeutic outcomes in carcinoma of the uterine cervixPractice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus StatementImpact of boost irradiation on pelvic lymph node control in patients with cervical cancer.
P2860
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A phase II trial of less than ...... ally advanced cervical cancer.
@en
A phase II trial of less than ...... ally advanced cervical cancer.
@nl
type
label
A phase II trial of less than ...... ally advanced cervical cancer.
@en
A phase II trial of less than ...... ally advanced cervical cancer.
@nl
prefLabel
A phase II trial of less than ...... ally advanced cervical cancer.
@en
A phase II trial of less than ...... ally advanced cervical cancer.
@nl
P2093
P1476
A phase II trial of less than ...... cally advanced cervical cancer
@en
P2093
Jaime Espinós
José Manuel Aramendía
Leire Arbea
Matías Jurado
Miren Gaztañaga
Rafael Martínez-Monge
P304
P356
10.1111/IGC.0B013E3181C057FF
P577
2010-01-01T00:00:00Z